A lower appeals court ruling allowing human genes to be patented has been overturned by the U.S. Supreme Court, which sends the case back down for a continuation of the battle between those who believe that genes carrying the secrets of life should not be exploited for commercial gain and companies who argue that a patent must be the reward for years of expensive research that moves science forward.
The ruling again overturns patents belonging to Myriad Genetics Inc. of Salt Lake City on two genes linked to increased risk of breast and ovarian cancer. Myriad's BRACAnalysis test looks for mutations on the breast cancer predisposition gene, or BRCA. Now they must go back for a rehearing and the impact could be substantial.
The U.S. Patent and Trademark Office has been awarding patents on human genes for almost 30 years.
The case is Association for Molecular Pathology v. Myriad Genetics, 11-725.
Supreme Court throws out human gene patents, Associated Press, Monday, March 26, 2012
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Questions a Surface Pro 3 user has about Windows 10.
- Top Mass: CMS Again On Top!
- Sterile Neutrinos Remain Elusive
- How Myths And Tabloids Feed On Anomalies In Science
- Epigenetics Of Being Without Electricity For A Few Days
- Why Crowdfunding Publisher Unbound Poses A Threat To Literary Prizes
- Science Graduates Are Not Good At Math – But Why?
- "I don't know about that. MS makes much of it's money off enterprises. Massive multinational..."
- "Lol, I don't have any problem with that...."
- "There is only one scientific understanding of the neuron-behavior linkage: Kandel et al spent 30..."
- "No wonder you have a problem comprehending climate change!..."
- "There are many truths of which the full meaning cannot be realized until personal experience has..."